RAM
AGIO icon

Riggs Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Riggs Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$100 – 138
2025
Q2 		$100 Sell
3
-38
-93% -$1.15K ﹤0.01% 906
2025
Q1 		$1.2K Hold
41
– – ﹤0.01% 460
2024
Q4 		$1.35K Hold
41
– – ﹤0.01% 413
2024
Q3 		$1.82K Hold
41
– – ﹤0.01% 378
2024
Q2 		$1.77K Hold
41
– – ﹤0.01% 381
2024
Q1 		$1.2K Buy
+41
New +$1.1K ﹤0.01% 396

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Riggs Asset Management's AGIO Position: Q3 2025 in Review

Riggs Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 3 shares — an estimated $100 sold.

Riggs Asset Management first reported a position in AGIO in Q1 2024 and held it in 6 quarters. The position peaked at $1.82K in Q3 2024. 221 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Riggs Asset Management reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 3 Agios Pharmaceuticals shares in Q3 2025, an estimated $100.
  • Riggs Asset Management first reported a position in Agios Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • Riggs Asset Management's Agios Pharmaceuticals position peaked at $1.82K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.